Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

482
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
482
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

96
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
96
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

114
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
114
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

155
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
155
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

150
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
150
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

720
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
720

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiological and pathogen characteristics of symptomatic male reproductive tract infections in Hunan province: retrospective study.

Scientific reports·2026
Same author

Targeted next-generation sequencing in diagnosing reproductive tract infections: a comparative study.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

WeMol: A Cloud-Based and Zero-Code Platform for AI-Driven Molecular Design and Simulation.

Journal of chemical information and modeling·2026
Same author

Discovery of benzimidazole-based Mcl-1 inhibitors via AlphaShape-enabled virtual screening.

European journal of medicinal chemistry·2025
Same author

Comparative diagnostic performance of metagenomic and two targeted sequencing methods in lower respiratory infection.

Scientific reports·2025
Same author

Regulating the Conductive Network of Graphene/Ni Composite Films toward Tunable Electromagnetic Shielding Efficiency.

ACS applied materials & interfaces·2024

Related Experiment Video

Updated: Apr 23, 2026

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

13.8K

Predicting dual-targeting anti-influenza agents using multi-models.

Yu Wang1, Hu Ge, Yali Li

  • 1School of Pharmaceutical Sciences & Institute of Human Virology, Sun Yat-Sen University, 132 East Circle Road at University City, Guangzhou, 510006, China.

Molecular Diversity
|October 3, 2014
PubMed
Summary

Developing new dual-targeting anti-influenza agents is crucial due to rapid drug resistance. This study presents a novel virtual screening protocol to identify promising drug candidates targeting hemagglutinin (HA) and neuraminidase (NA) simultaneously.

More Related Videos

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

9.8K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

20.3K

Related Experiment Videos

Last Updated: Apr 23, 2026

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

13.8K
Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

9.8K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

20.3K

Area of Science:

  • * Virology and Drug Discovery
  • * Computational Chemistry and Bioinformatics

Background:

  • * Influenza is an acute respiratory illness caused by influenza viruses, with subtypes differentiated by hemagglutinin (HA) and neuraminidase (NA) surface glycoproteins.
  • * Rapid evolution of drug resistance in influenza viruses presents a significant challenge for developing effective antiviral therapies.
  • * Dual-targeting anti-influenza agents offer a promising strategy to overcome resistance by inhibiting multiple viral components.

Purpose of the Study:

  • * To develop and validate a novel, rationally designed virtual screening protocol for identifying dual-targeting anti-influenza agents.
  • * To screen for compounds that simultaneously inhibit both hemagglutinin (HA) and neuraminidase (NA) proteins of the influenza virus.
  • * To assess the potential of identified compounds as novel therapeutic agents against influenza.

Main Methods:

  • * Integration of structure-based methods (molecular docking, molecular dynamic simulations) and ligand-based methods (support vector machines, 3D shape & electrostatic similarity algorithms).
  • * Application of a consensus approach combining ligand and receptor knowledge for HA and NA targets.
  • * In silico evaluation of drug-likeness using ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) predictions.

Main Results:

  • * The developed virtual screening protocol successfully identified potential dual-targeting agents against HA and NA.
  • * Binding energy calculations and binding mode analyses indicated promising interactions for several hit compounds.
  • * ADMET predictions provided initial assessments of the pharmacokinetic and safety profiles of the identified candidates.

Conclusions:

  • * The study successfully demonstrated a robust virtual screening strategy for discovering dual-acting anti-influenza agents.
  • * Several identified compounds show potential as novel therapeutic leads for combating influenza infections.
  • * The presented virtual screening protocol can be adapted for the discovery of innovative drugs in other therapeutic areas.